EBS Cash & Short-Term Investments

Emergent Biosolutions Inc · Cash & Short-Term Investments

EBS logo

EBS Cash & Short-Term Investments

Latest reported$205.40M
EBS FY Cash & Short-Term Investments ($5.85M → $205.40M)
High-resolution chart · PNG

EBS cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
205,400,000
99,500,000
111,700,000
642,600,000
576,300,000
621,300,000
168,000,000
112,200,000
178,292,000
271,513,000
312,795,000
280,499,000
179,338,000
141,666,000
145,867,000
171,048,000
102,924,000
91,473,000
105,730,000
76,418,000
36,294,000
6,821,000
4,891,000
5,854,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.